Use of Machine Learning to Optimize Referral for Early Palliative Care: Are Prognostic Predictions Enough? In the article that accompanies this editorial, Camus et al 7 have updated and reanalyzed ...
Peripheral T-cell lymphoma (PTCL) is an aggressive tumor derived from mature T cells and natural killer cells with an extremely poor prognosis. Ferroptosis is a mechanism of cell death that is ...
It develops from the abnormal multiplication of T cells, or T-lymphocytes, a type of white blood cell essential for immune system function. The specific treatment course and prognosis for T-cell ...
Among 88 heavily pretreated patients evaluable for efficacy, 44% (95% CI 34-55) responded to single-agent golidocitinib, with 24% (95% CI 15-34) achieving a complete response, reported Jun Zhu, MD, of ...
In Asia, PTCL diagnosis and management are hindered by the lack of available domain experts, limitations in infrastructure support and funding, and substantial challenges in accessing novel drugs; ...
The TERZO study evaluates Copiktra for relapsed or refractory nodal T-follicular helper cell lymphoma, lacking a standard treatment. The trial compares Copiktra with Gemzar or Bendeka, focusing on ...
The T-cell lymphoma occurred in a patient who received CAR T-cell therapy for a diffuse large B-cell lymphoma (DLBCL). Molecular, genetic, and cellular analyses showed the two lymphomas had distinct ...
T-follicular helper (TFH) lymphoma is a blood cancer subgroup that continues to demonstrate a generally poor prognosis, with no standard treatment established to date. Although specific genetic ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback